Table 1.
Mode of disinhibition | Presynaptic interneuron | Molecular marker | CA1 target interneuron | Method | Publication(s) |
---|---|---|---|---|---|
Interneuron-specific (IS) inhibition | IS-1 | CR | CB IN (SCA, PPA); CCK/VIP BC; IS-1 | immunocytochemistry; electron microscopy | Acsády et al.92 and Gulyás et al.93 |
IS-3 | paired recording, in vitro | Luo et al.94 | |||
IS-2 | VIP | SCA, PPA, IS-2, CCK/VIP BC | immunocytochemistry; electron microscopy |
Gulyás et al.93 | |
IS-3 | paired recording, in vitro | Luo et al.94 | |||
IS-3 | VIP; CR | O-LM, BiC, CCK/VIP BC, O-O | paired recording, in vitro | Tyan et al.95 | |
IS-3 | paired recording, in vitro | Luo et al.94 | |||
VIP-LRPa | VIP; M2R; CB | O-LM, BiC, CCK BC | paired recording, in vitro | Francavilla et al.61 | |
Non-IS homotypic inhibition | CCK-BC | CCK; CB1Rb | CCK BC | paired recording, in vitro | Daw et al.96 |
PV BC | PV | PV BC | paired recording, in vitro | Daw et al.96 and Cobb et al.97 | |
SCA | CCK; CB | CCK SCA | paired recording, in vitro | Ali98 | |
NGFC | NPY; nNOS | NGFC | paired recording, in vitro | Price et al.99 | |
Non-IS heterotypic inhibition | O-LM | SOM; mGluR1α; (PV) | CCK BC, SCA, PPA, NGFC | paired recording, in vitro | Elfant et al.100 |
CCK-BC | CCK; CB1Rb | PV BC | paired recording, in vitro | Karson et al.101 | |
PV BC | PV | CCK BC | optogenetics and Ca2+ imaging, in vitro and in vivo | Dudok et al.13 | |
TORO | M2R | PV- and CCK-expressing IN | immunocytochemistry | Szabo et al.20 | |
AAC | paired recording, in vitro | Szabo et al.20 | |||
Extrahippocampal GABAergic, long-range input | septo-hippocampal | not specified | PV- and CB-expressing IN | immunocytochemistry, anterograde tracing; electron microscopy | Freund and Antal102 |
PV | not specifiedc | antero- and retrograde, and AAV tracing; immunocytochemistry; electron microscopy |
Unal et al.103 | ||
PV; SATB1; HCN4 | BiC | juxtacellular labeling, electrophysiology immunocytochemistry | Unal et al.104 | ||
GAD67 (not further specified) | PV-, CB-, CR-, SOM-expressing INd | immunocytochemistry; optogenetics, in vivo and in vitro | Sans-Dublanc et al.105 | ||
mGluR8a; in terminals | trilaminar IN (M2R+) | anterograde labeling | Katona et al.59 | ||
not specifiede | TORO | optogenetics and Ca2+ imaging, in vivo and in vitro | Szabo et al.20 | ||
PFC-hippocampal | PV; Som; VIP; CR; NPYf | VIP-expressing IN | optogenetics and Ca2+ imaging, in vivo and in vitro | Malik et al.106 |
Abbreviations: IN, interneuron; SCA, Schaffer-collateral associated; PPA, perforant path associated; O-O, Oriens-oriens; SATB1, special AT-rich sequence binding protein 1; HCN4, hyperpolarization-activated cyclic nucleotide-gated channel isoform 4; GAD67, glutamate decarboxylase isoform 67.
VIP-LRP INs target both PCs and INs in the subiculum61 and thus, strictly speaking, these cells can only be considered interneuron-specific within CA1.
Based on the available literature, it is unclear whether these CCK-expressing BCs belong to the VIP or VGlut3-expressing group.
Postsynaptic targets in the subiculum included PV-, CB-, CR-, NECAB1-, CCK- and Reelin-expressing IN, among others.
The majority of postsynaptic somata was found in the pyramidal cell layer. Fractions of postsynaptic somata expressing PV: 44%, CB: 22%, CR: 18%, SOM: 9%, CCK: 4%, VIP: 3%.
Medial septum GABAergic neurons were labeled using Dlx5/6-Cre transgenic mice and Cre-dependent viral constructs.
Prefrontal cortex GABAergic neurons were labeled using Dlxi12b-Cre transgenic mice and Cre-dependent viral constructs.